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BMP signalling differentially regulates distinct
haematopoietic stem cell types
Mihaela Crisan1,2, Parham Solaimani Kartalaei1,2, Chris Vink1,2, Tomoko Yamada-Inagawa1, Karine Bollerot1,
Wilfred van IJcken3, Reinier van der Linden1, Susana M.Chuva de Sousa Lopes4, Rui Monteiro4,
Christine Mummery4 & Elaine Dzierzak1,2
Adult haematopoiesis is the outcome of distinct haematopoietic stem cell (HSC) subtypes
with self-renewable repopulating ability, but with different haematopoietic cell lineage
outputs. The molecular basis for this heterogeneity is largely unknown. BMP signalling
regulates HSCs as they are ﬁrst generated in the aorta-gonad-mesonephros region, but at
later developmental stages, its role in HSCs is controversial. Here we show that HSCs
in murine fetal liver and the bone marrow are of two types that can be prospectively
isolated—BMP activated and non-BMP activated. Clonal transplantation demonstrates that
they have distinct haematopoietic lineage outputs. Moreover, the two HSC types differ in
intrinsic genetic programs, thus supporting a role for the BMP signalling axis in the
regulation of HSC heterogeneity and lineage output. Our ﬁndings provide insight into
the molecular control mechanisms that deﬁne HSC types and have important implications for
reprogramming cells to HSC fate and treatments targeting distinct HSC types.
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U
nderstanding the signalling pathways and mechanisms by
which haematopoietic stem cells (HSCs) sustain their
robust homoeostatic and regenerative characteristics is
important for disease treatments that may differentially affect
HSC subtypes. Long-term repopulating HSC subtypes have
been deﬁned by their haematopoietic lineage output—myeloid–
lymphoid balanced (Bala) HSCs, myeloid-biased (My) HSCs
and lymphoid-biased (Ly) HSCs. The clonal composition of
the HSC compartment is age-dependent1–4. Bala-HSCs are
found throughout ontogeny, Ly-HSCs predominate in young
individuals and My-HSCs predominate in older individuals2–4.
The molecular basis for HSC subtypes is hindered by the lack
of prospective isolation. Since bone morphogenetic protein
(BMP) affects the development of HSCs in the embryo, HSC
subtypes may be differentially controlled by the BMP signalling
pathway. It is known that high concentrations of BMP4 maintain
proliferation and repopulating activity of human cord blood
HSCs5. However, it has also been shown that conditional
inactivation of BMPR1a increases the number of bone marrow
(BM) HSCs6, that the canonical BMP pathway is dispensable in
embryonic day 14 (E14) fetal liver (FL) and adult BM7 and that
inhibition of Smad-dependent BMP signalling enhances homing
and engraftment of BM HSCs8. Since the role of BMP in HSC
regulation is as yet uncertain, we examined whether HSCs in the
embryo, fetus and adult are directly responsive to BMP signalling
and the relationship of BMP signalling to HSC heterogeneity.
Here we show in BMP responsive element (BRE) GFP
transgenic mouse embryos9 that all HSCs emerging in vivo in
the aorta-gonad-mesonephros (AGM) region are BMP activated.
In contrast, HSCs in murine FL and BM are of two types—BMP
activated and non-BMP activated. The initially high proportion of
BMP-activated HSCs decreases through ontogeny, and is
surpassed by HSCs that are non-responsive to BMP. Clonal
transplantation of the two BM HSC types demonstrates that
HSC lineage output correlates with the state of BMP activation.
Moreover, the two HSC types differ in intrinsic genetic programs
thus supporting a role for the BMP signalling axis in the
regulation of HSC heterogeneity and lineage output.
Results
All AGM HSCs in vivo are BMP-activated. The localized pro-
duction of BMP4 in the AGM10–12 and BMPR2 expression by
enriched AGM haematopoietic progenitors and stem cells
(HPSCs)10 suggests that BMP may act directly on HSCs. We
examined the BMP activation status of HSCs during ontogeny in
BRE–GFP transgenic mice. GFP is expressed in BRE–GFP mice
when BMP and the BMP receptor signal through Smad1/5 to
activate transcription from the BRE sequence (Fig. 1a). GFP
expression denotes BMP activation at the moment of cell
observation/isolation and does not represent previous BMP
activation history. Importantly, all BRE–GFP-expressing cells
also express pSmad1/5/8 (ref. 13). Three-dimensional imaging of
whole-mount immunostained transgenic E10.5 embryos shows
that BMP-activated (GFPþ ) cells are predominantly distributed
in the ventral aspect of the aorta (lumenal hematopoietic,
endothelial and underlying mesenchymal cells; Fig. 1b). HPSCs
are known to reside in the haematopoietic clusters closely
associated with the aorta14–16. Some cluster cells are GFPþ
(Fig. 1c), suggesting heterogeneity in BMP activation within the
HPSC compartment at the time of HSC generation. To test the
BMP activation status of HSCs, E11 AGM GFPþ and GFP cells
were sorted (6.2±3.1%(mean±s.d.) of E11 AGM cells are
GFPþ ; Fig. 1d, Supplementary Fig. 1A) and transplanted into
adult irradiated recipient mice. All AGM HSCs were found in the
BMP-activated fraction (Fig. 1e): 3 out of 7 recipients receiving
GFPþ AGM cells were long term, high level repopulated (410%
chimerism) by donor cells, whereas no recipients (0 out of 7)
receiving GFP AGM cells were donor engrafted (P¼ 0.05), even
when high embryo equivalents of cells were injected. These data
show that BMP signalling is activated in HSCs when they are
ﬁrst detected in the AGM.
Two HSC types can be prospectively isolated from FL and BM .
Examination of the BMP activation status of the cells in the BRE–
GFP E14 FL and adult BM revealed that 3.7±0.5% (mean±s.d.)
and 5.5%±1.8 (mean±s.d.) of cells, respectively, were GFPþ
(Fig. 2a,c; Supplementary Fig. 1A). When sorted BRE–GFP E12–
E14 FL or adult BM cells were transplanted, HSCs were found in
both fractions, GFPþ and GFP . Recipient mice were found to
be long-term, high level repopulated (Fig. 2b,d) and secondary
transplantation of BM from primary recipients showed that the
HSCs self-renew (Fig. 2b,d). Thus, the FL and BM contain two
types of HSCs—BMP activated and non-BMP activated. The
percentage of phenotypic HSCs (LSK-SLAM; LinSca1þ cKitþ
CD150þCD48 ) in E14 FL is signiﬁcantly higher in the BMP-
activated fraction (73%) than in the non-BMP-activated fraction
(27%; n¼ 5, T-test Po0.001; Fig. 2e,f). In contrast, in the BM, the
majority (92%) of the phenotypic LSK-SLAM HSCs is non-BMP
activated (Fig. 2g,h). BMP activation as detected by BRE–GFP
expression allows prospective isolation of the two HSC types to
enable study of their molecular and functional characteristics.
The expression proﬁles of the BMP-activated and
non-activated HSCs as examined by RNA sequencing show
distinct genetic programs (Fig. 3). FL and BM LSK-SLAM GFPþ
HSCs express Bmpr genes, whereas GFP LSK-SLAM HSCs
do not (Fig. 3a). Smad genes are expressed in both fractions.
Genes upregulated in the GFPþ FL and BM HSC fractions
are signiﬁcantly enriched in BMPR2 downstream targets,
conﬁrming BMP signalling activation (Fig. 3b). Moreover, other
categories/gene sets were found to be differentially expressed
between the two HSC types. For example, sets common to FL
and BM upregulated in the BMP-activated HSCs are signiﬁcantly
enriched for genes involved in homoeostasis and metabolism,
and MYC and STAT5B target genes (Fig. 3c). Upregulated sets in
the non-BMP-activated HSCs are signiﬁcantly enriched for
genes involved in haematopoietic system development,
NFKB1, SP1 and NFE2 target genes (Fig. 3d; see ﬁgure legend
for false discovery rate corrected Fisher exact test P values).
As some of these transcription factors affect normal and
malignant haematopoietic cells and speciﬁc haematopoietic
lineages, the distinct programs may inﬂuence the functional
characteristics of the two HSC types.
BM HSC output correlates with BMP activation status. Lim-
iting dilution and clonal transplantations were performed to
examine the frequency and functional properties of BMP-
activated and non-activated HSCs. We found that a high
frequency of FL GFPþ cells are HSCs (1 out of 180), whereas
only 1 out of 20,545 FL GFP cells is a HSC (Fig. 4a;
Supplementary Table 1). Given that the FL contains a mean of
12.7 106 cells, of which 3.7% are GFPþ , our data demonstrate
that 81% of FL HSCs are BMP activated, with 19% being non-
BMP activated (Fig. 4b). This corresponds well
with the percentages of GFPþ and GFP cells found in the
FL LSK-SLAM phenotypic HSC compartment. In contrast,
the non-BMP-activated HSC number is signiﬁcantly higher in the
adult BM (Fig. 4c,d). One in 10,053 BM GFPþ cells and 1 in
17,760 BM GFP cells is an HSC (Supplementary Table 2).
Taking into account an average of 2 107 BM cells per mouse
(four long bones), of which 5.5% are GFPþ , we ﬁnd that 9% of
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BM HSCs are BMP activated and 91% are non-BMP activated.
This is in correspondence with the percentages of GFPþ and
GFP cells found in the BM LSK-SLAM phenotypic HSC
compartment. The inversed percentages of BMP-activated HSCs
in the BM as compared with the FL are likely due to time- and/or
niche-related ontogenic changes.
Considering this shift in the number of BMP-activated HSCs
with developmental time and the data of others showing that
there are changes in the clonal composition of the HSC
compartment associated with lineage output2, we tested the
lineage output of BMP-activated and non-activated HSCs. Clonal
transplantations of GFPþ and GFP HSCs from FL and adult
BM (injected cell number was calculated by limiting dilution
experiments) were performed and the peripheral blood lineage
output data at 4 months post-transplantation was analysed
according to Cho et al.2 (Supplementary Fig. 1B). Only
primary recipients that were reconstituted in both lymphoid
and myeloid lineages were considered. Our data in the FL
show slight differences in the lineage output composition of
HSCs, with more Bala-HSCs in the BMP-activated fraction.
However, this did not reach signiﬁcance (Supplementary
Fig. 1C,D; Supplementary Table 3). In contrast, BMP-activated
and non-BMP-activated HSCs in the BM were signiﬁcantly
different in terms of HSC lineage output composition (P¼ 0.007).
Bala-HSCs were signiﬁcantly enriched in the BMP-activated
HSC fraction: 7 out of 17 in the GFPþ as compared with 0 out
of 15 in the GFP fraction (P¼ 0.005) (Fig. 4e; Supplementary
Table 3). My-HSCs were signiﬁcantly enriched in the non-
BMP-activated fraction: 7 out of 15 in GFP compared with 2
out of 17 in the GFPþ (P¼ 0.031; Fig. 4f; Supplementary
Table 3). Ly-HSCs were equally distributed (8 out of 17 and 8 out
of 15; P¼ 0.727) (Fig. 4e,f; Supplementary Table 3).
Thus, prospective isolation of predominantly balanced and
myeloid-biased HSCs is achieved in the BM by cell sorting
based on BMP activation.
The two HSC types differ in their intrinsic molecular programs.
Previously, it has been suggested that common lymphoid
progenitor cells (CLPs) derived from clonal transplantation of
lymphoid–myeloid HSCs are poised for expression of lymphoid
regulator genes17. We examined whether the expression of such
lymphoid genes are already present in LSK-SLAM HSCs and are
associated with BMP activation status. Whereas 88% of GFPþ BM
HSCs have enhanced lymphoid differentiation potential
(Balaþ Ly), this potential is present in only 53% of HSCs in the
GFP fraction (Supplementary Table 3). Moreover, RNA
sequencing data showed that the GFPþ BM HSCs have higher
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Figure 1 | Aorta-gonad-mesonephros HSCs are BMP activated. (a) Scheme showing activation of the canonical BMP signalling pathway through
phospo-Smad1/5 binding of the double BMP responsive element (BRE) and the resulting transcription of GFP. (b) Three-dimensional whole-mount image of
an E10.5 immunostained BRE–GFP mouse embryo (37 somite pairs). Anti-CD31 (magenta), cKit (red) and GFP (green) antibody staining shows the
predominantly ventral distribution of GFPþ cells in various cell types within the aorta and underlying mesenchymal cells. (c) High-magniﬁcation image of a
transverse section of an E11 BRE–GFP dorsal aorta stained with anti-GFP-antibody and 4,6-diamidino-2-phenylindole (DAPI). Intra-aortic hematopoietic
clusters contain GFPþ and GFP cells. Some endothelial cells are GFPþ. (d) Representative FACS plot with side scatter on the y axis showing percentage
of E11 AGM GFPþ cells (see Supplementary Fig. 1A for control). (e) Percentage donor cell chimerism in the peripheral blood of adult irradiated transplant
recipients at 4 months after injection of E11 AGM GFPþ and GFP cells (2–4.5 embryo equivalents (ee) of AGM cells injected per mouse; n¼ 3
independent transplantation experiments). *P¼0.05 by z-Test for proportions.
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Fragments per kilobase of transcript per million mapped reads
(FPKM) values for Ikaros (Ikzf1), E2A (Tcf3) and Flt3 genes than
GFP HSCs, supporting a pro-lymphoid transcriptional
programme for BM BMP-activated HSCs. This is not observed
in the FL where similar proportions of HSCs with enhanced
lymphoid differentiation potential exist in both GFPþ (96%)
and GFP (97%) fractions (Supplementary Table 3). FPKM
values of the lymphoid genes are comparable in these fractions
(Supplementary Fig. 1E). These data suggest that the BM
microenvironment promotes a pro-lymphoid gene programme in
subset of HSCs activated by the BMP signalling pathway. These
results on HSC lineage output, together with the clear differences
in the genetic programs between BMP-activated and non-BMP-
activated HSCs, suggest the BMP signalling axis as an underlying
basis for HSC heterogeneity.
Discussion
The BMP activation marker that we used in this study represents a
robust method by which functionally distinct types of HSCs can be
prospectively enriched. Other methods previously used such as
label retention18, ckit expression levels19, Hoechst dye efﬂux
levels20 and CD229 provide limited separation17. It was shown that
TGFb1 differentially controls Ly- and My-HSCs20. However, the
variation between the individual HSC clones found in this study
suggests that HSC subtype segregation is not absolute. Indeed, as
we show here only a subset of Ly-HSCs are controlled by the BMP
pathway. Interestingly, TGFb1 appears to be a general stimulatory
factor for My-HSC proliferation20. This is in line with our study
showing that in BM, in absolute number, there are signiﬁcantly
more My-HSCs in the non-BMP-activated fraction and these are
likely to be controlled by the TGFb pathway.
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Figure 2 | The fetal liver (FL) and bone marrow contain two distinct HSC types. Representative FACS plots showing percentage of GFPþ cells with side
scatter shown on the y axis in the (a) E14 FL and (c) adult bone marrow (BM) of BRE–GFP mice (see Supplementary Figure S1A for controls).
Transplantation results of adult irradiated recipients injected with GFPþ and GFP cells sorted from (b) E12, E13 or E14 FL (n¼ 3) or (d) adult BM (n¼4).
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The ability to prospectively identify the distinct HSC types
based on BMP activation and directly measure the clonal
composition of the HSC pool highlights the importance of the
BMP signalling axis in directing the intrinsic HSC programme
during ontogeny. MYC and STAT5b target genes that are
enriched in the BMP-activated HSCs are, respectively, known
to be important in the balance between differentiation and
self-renewal, and for conferring efﬁcient lympho–myeloid
repopulation and quiescence properties21,22. Of the (NFE2, SP1
and NFKB1) targets upregulated in the non-BMP-activated
HSCs, NFE2 is often overexpressed in the myeloproliferative
disorders, which spontaneously transform to acute myeloid
leukaemia and polycythemia23. SP1 and NFKB1 are known to
regulate HSC speciﬁcation and are required for normal HSC
function and differentiation24,25. Interestingly, aged HSCs express
high levels of NFKB3,26. This is in line with our data showing that
the non-BMP-activated BM HSCs are high in NFKB and are
predominantly myeloid biased. These transcriptomic proﬁles
together with further studies should provide insight into how
HSC clonal composition may be regulated.
Our ﬁnding of the existence of non-BMP-activated HSCs now
provides an explanation for the absence of a haematopoietic
phenotype when the canonical BMP signalling pathway is
impaired6–8. In the absence of BMP-activated HSCs, the
non-activated HSCs are not only sufﬁcient to assume
the normal haematopoietic function, but may also expand. The
earliest AGM HSCs are BMP activated and as development
progresses and HSCs reside in other tissues, there is a shift in
the ratio of HSC types from being predominantly BMP activated
in the FL to being predominantly non-BMP activated in the
adult BM. This implies quantitative changes in BMP-producing
niches during the migration process from the AGM (BMPhigh) to
FL and eventually multiple BM niches (osteoblastic, perivascular
and neural) with variable BMP levels (BMPhigh versus BMPlow)
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or intrinsic changes in HSC BMP receptor expression with
developmental time. Future studies should examine the speciﬁc
niches supporting the two HSC types in the FL and BM for BMP
production, and examine whether other signalling molecules
regulate the non-BMP-activated HSCs. Deciphering the
behaviour and lineage output of HSCs during ontogeny,
understanding whether the two HSC types are interchangeable
or have different origins and investigating the underlying intrinsic
and extrinsic mechanisms that dictate these changes are of
importance for ensuring that HSCs created through
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cent donor contribution and donor percentage of GM and BþTwere calculated according to Cho et al.2, to reveal HSC type in each recipient. P values were
calculated by Fisher exact test between the GFPþ and the GFP fractions (P¼0.007) and by two sample test for proportion (w2) between balanced
(*P¼0.005), My (**P¼0.031) and Ly-HSCs (P¼0.727) of the two groups, GFPþ and GFP. (g) Fragments per kilobase of transcript per million mapped
reads (FPKM) values for selected lymphoid genes expressed by GFPþ and GFP LSK SLAM sorted HSCs from adult BM.
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reprogramming strategies will be capable of generating all
the desired cell types, and for understanding why speciﬁc
haematological malignancies are prevalent in paediatric versus
elderly patients27. Our ﬁndings may be of particular interest to
drug resistance in acute myeloid leukaemia patients28, raising the
question of whether a combination of drugs affecting the distinct
HSC types would be more efﬁcient to control blood-related
disorders.
Methods
Mice and embryo generation. Mice were bred and housed at Erasmus MC.
BRE GFP transgenic mice9 were maintained in C57BL/6 background. Two
independently derived transgenic lines were used in this study. Data from line 1 are
shown. Matings were set-up between heterozygous BRE GFP transgenic male and
wild-type C57BL/6 female mice. The day of vaginal plug detection was designated
as E0. All animal procedures were approved by the local ethics committee and
performed in compliance with Standards for Care and Use of Laboratory Animals.
Whole-mount immunostaining and immunohistochemistry. Whole-mount
embryo immunostaining and three-dimensional imaging were performed as
described previously16,29. Embryos were ﬁxed for 20min with 2% PFA/PBS at 4 C;
dehydrated in graded concentrations of methanol; stained with primary antibodies-
unconjugated rabbit anti-GFP (MBL, 1:2000), biotinylated rat anti-CD31 (BD,
1:500) and subsequently with rat anti-cKit (BD, 1:500) antibodies in blocking
buffer ON at 4 C; washed; incubated with secondary antibodies goat anti-rabbit
IgG-Alexa Fluor488 (Invitrogen, 1:1,000), goat anti-rat IgG-Alexa Flour647
(Invitrogen, 1:5,000) and donkey Streptavidin-Cy3, (Jackson ImmunoResearch,
1:1,000); made transparent in BABB; and analysed with a confocal microscope
(Zeiss LSM 510META JNI, Plan-Neoﬂuar  10/0.3, Eppiplan-Neoﬂuar  20/
0.50). Three-dimensional reconstructions were generated from z-stack with LSM
Image Browser (Zeiss) and Amira (VISAGE IMAGING).
Flow cytometry. AGMs were dissected with needles under the microscope as
previously described30 and tissues were dissociated in PBS/FCS/PS with collagenase
type I (Sigma, 0,125%) in water bath at 37 C for 45min. Cells were further
mechanically separated by ﬂushing with a pipette, washed with PBS/FCS/PS and
centrifuged at 1,000 r.p.m. for 10min at 4 C. Pellets were resuspended in PBS/FCS/
PS. E14 FL were mechanically disrupted until a homogeneous cell suspension was
obtained. Adult BM was harvested from tibias and femurs by ﬂushing with
PBS/FCS/PS through a 1-ml syringe with a 25-G needle. Ficoll fractionation of BM
cells was performed at 2,000 r.p.m., 20min at room temperature. Mononuclear
cells were harvested and washed with PBS/FCS/PS followed by centrifugation at
1,000 r.p.m., 10min at 4 C. Viable cells were counted by Trypan Blue exclusion
(Sigma, 0.4%).
FL and adult BM LSK/SLAM cell stainings included LinPE cocktail (anti-CD3/
1:400, anti-B220/1:2000, anti-Ter119/1:400, anti-Ly6c/1:4000 antibodies),
anti-Sca1PE-Cy7(1:800), anti-cKitAPC-Alexa Fluor780(1:600) or BV421(1:500),
anti-CD48PE(1:500) and anti-CD150APC(1:500) antibodies. Anti-CD11b-PE
antibody (1:2,000) was added in the Lin staining for adult BM. Cells were analysed
on a FACSAria SORP or FACSAria III (BD) with FloJo software. Dead cell exclusion
was with Hoechst 33258 (1:10,000, Molecular Probes). Lineage output was tested on
primary recipient peripheral blood at 4 months post transplantation using myeloid
lineage (GM) markers, anti-CD11b PE and anti-Ly6c PE antibodies, lymphoid
lineage (BþT) markers, anti-CD3APC(1:400) and anti-B220APC(1:2,000)
antibodies and the donor marker with anti-CD45.2 FITC(1:500) antibody. All
antibodies used were from BD Pharmingen except the anti-CD150 antibody
(eBiolegend). Haematopoietic lineage output in peripheral blood of clonal transplant
recipients (4 months post transplantation) was considered balanced when the
BþTvalue/GMvalue/ was 4–16, myeloid-biased when the ratio was 0–4 and
lymphoid-biased when the ratio was 416.
Transplantation assay. Single cell suspensions were injected intravenously into
female ((129SVC57BL/6)F1 or Ly5.1) mice (3–6 months old) irradiated with 9Gy
(split dose, 137Cs source). A total of 2 105 recipient background spleen cells were
co-injected. BM cells from primary recipients were injected into irradiated (9Gy,
split dose) secondary recipients. For (129SVC57BL/6) F1 recipients, peripheral
blood peripheral blood chimerism was quantiﬁed by DNA PCR for gfp and calcu-
lated by DNA normalization (myoD) and comparison with gfp contribution controls
with Image Quant software. Mice showing410% donor chimerism were considered
repopulated. For Ly5.1 recipients, peripheral blood chimerism was quantiﬁed by
CD45.1 and CD45.2 ﬂow cytometric analysis. Mice with 41% CD45.2þCD45.1
donor chimerism were considered repopulated. Secondary recipients received either
3 106 unsorted BM cells or GFPþ (1.5 105 cells per mouse) and GFP
(0.8 11.8 106 cells per mouse) from the reconstituted primary recipients. For
lineage output analysis, clonal HSC were transplanted based on frequencies found in
the limiting dilution experiments. Brieﬂy, GFPþ and GFP fractions from the BM
and FL were ﬁrst injected at different cell numbers in irradiated recipients and the
repopulation activity measured at 4 months post injection. Using the following
parameters, cell number transplanted and number of mice repopulated per number
of mice transplanted, frequencies of HSCs were calculated with the L-Calc Software
(StemCellTechnology). Subsequent transplants were performed with the cell
numbers containing 1 HSC.
RNA preparation and RNA sequencing. RNA was isolated from E14 and adult
BM with the mirVana miRNA Kit and prepared according to SMARTER protocol31
for the Illumina HiSeq2000 sequencer. The sequencing depth (unique mapped reads)
was for BM (GFPþ 1.21e07; GFP 1.11e07) and for the FL (GFPþ 1.22e07; GFP
9.63e06). Sequences were mapped to the mouse (NCBI37/mm9) genome and FPKMs
were calculated using Bowtie (v2.2.3), TopHat (v2.0.12) and Cufﬂinks (v2.2.1).
Differential expression was analysed using Cuffquant with fragment-bias and
multi-read corrections and normalized across all samples using Cuffnorm with
geometric library-size normalization32. Genes are ‘high in the BMP-activated HSC
fraction (GFPþ )’ when FPKM in GFPþ42 FPKM GFP in both BM and FL
LSK-SLAM cells, and ‘high in the non-BMP-activated fraction (GFP )’ when
FPKM in GFP42 FPKM GFPþ in both BM and FL LSK-SLAM cells. For gene
list enrichment analysis, genes were applied to Enrichr web application33. Gene sets
with enrichment false discovery rate of 0.01 were selected and heatmaps (row scaled)
were generated with ‘GFPþ high’ or ‘GFP high’ genes present in given enriched
genelists.
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